{
  "type": "ref",
  "text": "Functional inactivation of Foxp3 by genetic mutations affecting the Foxp3 coding region as demonstrated in IPEX or repression of Foxp3 expression by the HTLV-I-encoded transactivator protein Tax as recently reported in patients with HAM/TSP results in loss of regulatory activity in CD4+CD25hi T cells 4817.\n",
  "self": {
    "NER": {
      "answers": [
        "4817"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the number of CD4+CD25hi T cells affected by functional inactiv"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Functional inactivation",
        "genetic mutations",
        "the Foxp3 coding region",
        "IPEX",
        "expression",
        "the HTLV-I-encoded transactivator protein Tax",
        "patients",
        "HAM/TSP results",
        "loss",
        "regulatory activity"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the result of mutations in Foxp3?",
          "What causes functional inactivation of Foxp3?",
          "What part of the cell does the mutations affect?",
          "What is an example of a genetic mutation that can inactivate Foxp3?",
          "What is repressed by the HTLV-I-encoded transactivator",
          "What is the repression of Foxp3 by?",
          "What type of patients have recently reported a loss of regulatory activity in CD4+CD25",
          "What is the result of a repression of Foxp3 expression?",
          "What does the inactivation of Foxp3 result in in CD4+CD25h",
          "What does the loss of Foxp3 result in in CD4+CD25hi T"
        ]
      }
    }
  },
  "asked": {
    "What is the Foxp3 gene?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1256771683692932,
        "ground_truth": {
          "834": {
            "bertscore": 0.6319243907928467,
            "f1": 0
          }
        }
      }
    },
    "What supports our recent reports that high proviral loads are associated with reduced Foxp3 expression": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.026551127433776855,
        "ground_truth": {
          "They": {
            "bertscore": 0.6765639781951904,
            "f1": 0
          }
        }
      }
    },
    "What do these results support?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0012001991271972656,
        "ground_truth": {
          "our recent reports": {
            "bertscore": 0.6675443649291992,
            "f1": 0
          }
        }
      }
    },
    "What do the results of the HTLV-I-infected patients show?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3232816457748413,
        "ground_truth": {
          "high Tax mRNA": {
            "bertscore": 0.6780466437339783,
            "f1": 0
          }
        }
      }
    },
    "In what patients is high tax mRNA associated with reduced Foxp3 expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3206467032432556,
        "ground_truth": {
          "HTLV-I-infected patients": {
            "bertscore": 0.6184380054473877,
            "f1": 0
          }
        }
      }
    },
    "What is the result of high proviral loads?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00022095441818237305,
        "ground_truth": {
          "reduced Foxp3 expression": {
            "bertscore": 0.61970454454422,
            "f1": 0
          }
        }
      }
    }
  }
}